 eFitnessNow |
FDA extended time to review saxagliptin for treatment of diabetes
Endocrine Today, NJ The FDA has extended the date of the Prescription Drug User Fee Act from April 30, 2009 to July 30, 2009, stating that additional time is needed to complete the review of saxagliptin for the treatment of type 2 diabetes. … FDA extends timeline to approve diabetes drug of Bristol-Myers … diabetes_drug_Onglyza.html&cid=1339678364&ei=Hgf1SbukGqKcggOr9_yGDA&usg=AFQjCNEAsmMGKXwdDF-1ASODvUHyFyKw5A”>FDA wants more time to review diabetes drug Onglyza AstraZeneca: FDA Extends Timeline For Onglyza NDA To July 30 |
Your resource for controlling diabetes
Diabetes Treatment
FDA extended time to review saxagliptin for treatment of diabetes – Endocrine Today
Tags: DIABETES, Diabetes Treatment, TYPE 2
Categories
Tag Cloud
DIABETES Diabetes Symptoms Diabetes Treatment DIET EXERCISE GESTATIONAL Gestational Diabetes glucose tolerance test Juvenile Diabetes TYPE 2Most Emailed
- N/A
© 2009 Diabetes How To. 
Discussion
Comments are disallowed for this post.
Comments are closed.